Updated time: 2022-04-12 09:42:32
28T-1091019
2020-10-22
trade secret
The invention is a set of antibody library design and the antibody sequences which target SARS-CoV-2 N protein. Several antibodies that bind to SARS-CoV-2 N protein are used as templates. Sites of CDR regions are mutated randomly by using the phage display method to discover amino acid preference. The antibodies selected from the random libraries are used for the following process,
- Antibodies with better binding performance than the parental sequence are investigated for further development.
- Amino acid preferences of all randomly mutated CDR sites are collected from functional antibodies. These preferences are applied for new antibody library designs. The libraries are applied for anti-SARS-CoV-2 N protein screening.
- The antibody screening is in-vitro system which can produce multiple antibodies at the same time.
- The screening system is optimized for lateral flow devices.
- Antibodies can be further optimized if necessary.
- Lateral flow immunoassay for detecting SARS-CoV-2 N protein
- Combination of rapid test kits for upper respiratory tract. infection (corona virus and influenza virus, for example).
An-Suei Yang、Chung-Ming Yu、Chao-Ping Tung、Horng-Ru Hsu、Hung-Pin Peng、Chi-Yung Chen、Yu-Chuan Huang、Pei-Hsun Tsai、Szu-Yu Lin、Fei-Hung Hung
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

Antibody library design for detecting SARS-CoV-2 N protein